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Molecular predisposition of postnatal ventricular myocardium to chamber-dependent (concentric or eccentric) remodeling
remains largely elusive. To this end, we compared gene expression in the left (LV) versus right ventricle (RV) in newborn piglets,
using a diﬀerential display reverse transcription-PCR (DDRT-PCR) technique. Out of more than 5600 DDRT-PCR bands, a total
of 153 bands were identified as being diﬀerentially displayed. Of these, 96 bands were enriched in the LV, whereas the remaining
57 bands were predominant in the RV. The transcripts, displaying over twofold LV-RV expression diﬀerences, were sequenced and
identified by BLAST comparison to known mRNA sequences. Among the genes, whose expression was not previously recognized
as being chamber-dependent, we identified a small cohort of key regulators of muscle cell growth/proliferation (MAP3K7IP2,
MSTN, PHB2, APOBEC3F) and gene expression (PTPLAD1, JMJD1C, CEP290), which may be relevant to the chamber-dependent
predisposition of ventricular myocardium to respond diﬀerentially to pressure (LV) and volume (RV) overloads after birth. In
addition, our data demonstrate chamber-dependent alterations in expression of as yet uncharacterized novel genes, which may
also be suitable candidates for association studies in animal models of LV/RV hypertrophy.
1. Introduction
Ventricular (or cardiac) remodeling is commonly defined as
a physiological or pathological process that can occur under
various conditions of pressure/volume overload. A common
feature of ventricular remodeling is hypertrophy of the
cardiomyocytes. The type of cardiac workload determines
the pattern of ventricular hypertrophy: volume overload
induces eccentric, while pressure overload induces con-
centric remodeling. Under various pathological conditions,
compensatory concentric hypertrophy can lead to eccentric
hypertrophy, dilatory ventricular remodelling, and heart
failure (reviewed in [1, 2]). The molecular signature of
concentric versus eccentric hypertrophy, although poorly
defined as yet, is nevertheless of critical relevance in cardiac
basic and clinical research [3–8].
The early neonatal heart is a conventional model for
the study of distinct patterns of ventricular hypertrophy
(i.e., concentric versus eccentric). At birth, cardiomyocytes
begin to enlarge in response to the demands of physiological
workload, as opposed to processes driven predominantly by
developmental mechanisms. Particularly, the left ventricle
(LV) is exposed to a higher-pressure overload in comparison
to the right ventricle (RV), which is exposed to a relatively
higher-volume overload. As a result, the LV undergoes rapid
concentric hypertrophy, while the RV undergoes eccentric
hypertrophy associated with dilatory RV-chamber remodel-
ing. Our previous data revealed diﬀerences in the expression
of cardiac ankyrin repeat domain 1 factor (ANKRD1/CARP)
between the LV and RV before the appearance of morpho-
logically identifiable signs of LV-concentric or RV-eccentric
hypertrophy in newborn piglets [9]. Other research reported
certain LV/RV-specific metabolic diﬀerences in normal and
ischemic newborn piglet heart [7]. We interpreted these
results as reflecting a certain type of molecular predisposition
of newborn ventricular myocardium to LV-concentric and
RV-eccentric remodeling during postnatal development.
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Figure 1: Heart dimensions (a and b) and left/right ventricular cross-sections (c and d) of newborn and 20-day-old piglets. LV/RV—
left/right ventricle. (a), (b) Levels of cross sections are shown by dotted lines. (c), (d) Boundaries of the LV/RV free wall are marked by white
arrows.
In the present study, we focused on large-scale transcrip-
tomic analysis to compare diﬀerences in gene expression
levels in the LV versus RV in newborn piglets. Given that
commercially available DNA microarray platforms suitable
for performing transcriptional profiling in pig are still poorly
developed, we conducted comparative LV versus RV gene
expression profiling in newborn piglets using mRNA diﬀer-
ential display (DDRT-PCR). In addition, unlike microarray-
based platforms, DDRT-PCR can be used to detect expres-
sion changes in both known and novel transcripts including
alternate splice variants [10]. This approach allowed us (1) to
perform an unbiased assessment of genes which expression is
predominantly associated with piglet LV or RV myocardium
and (2) to distil a large body of expression data into a
discrete set of candidate genes for which regulation was not
previously recognized as being chamber-dependent. Further
studies on these diﬀerentially regulated genes will likely lead
to the identification of additional novel gene families and
pathways involved in the chamber-dependent response of
ventricular myocardium to a variety of physiological and
pathological stimuli.
2. Materials and Methods
2.1. Animals and Tissue Sampling. Animals were treated and
cared for in accordance with the European commission
directive 86/609/EEC on the protection of animals used for
experimental and other scientific purposes, and all animal
protocols were approved by the ethical research committee
of Galicia (Spain). Newborn (10–12 hours after birth) Large
White piglets were obtained from a local commercial breeder
(La Corun˜a, Galicia) and maintained in an automatic
nursery system (Nu¨tinger System). The newborn and 20-
day-old animals were anaesthetized, the thoracic cavity was
opened through a median sternotomy, and the entire heart
was rapidly removed, weighed, and photographed while still
beating. Then the isolated heart was placed on an ice-cold
petri dish, partially sectioned at the midpoint of the LV
length and photographs of the open ventricular chambers
were taken (Figure 1). Immediately after this step, the LV and
RV free walls were dissected, flash frozen in liquid nitrogen,
and stored at −80◦C until study.
2.2. RNA Isolation. Deep-frozen tissue samples (100–
150 mg), encompassing the full thickness of the free wall
of the LV and RV ventricle, were directly disrupted in RLT
buﬀer (Qiagen) using a high-speed rotor-stator homogenizer
(Ultra-Turrax T8, Germany), digested with Proteinase K
(Qiagen), loaded onto a RNeasy Midi column (Qiagen),
subjected to on-column digestion of DNA with RNase-free
DNase (Qiagen) and the analysis proceeded in accordance
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with the manufacturer’s recommendations. Resulting RNA
preparations were ethanol-precipitated, resolved in RNase-
free water, and kept at −80◦C. RNA yield and purity was
determined spectrophotometrically at 260–280 nm and RNA
integrity was verified by running samples on 1.5% agarose
gels and staining with ethidium bromide.
2.3. Diﬀerential Display mRNA Analysis. The reverse
transcription-PCR diﬀerential display (DDRT-PCR) analysis
was performed as described [11] with minor modifications
[12]. To yield starting material for the DDRT-PCR, total
RNA preparations independently isolated from the LV and
RV of three newborn piglets were, respectively, pooled at
equal ratios, and 4 μg of RNA was reverse transcribed using
the SuperScript III (Invitrogen) and T7-oligo-dT primer.
Pooled first-strand cDNAs were amplified side-by-side by
PCR using 230 diﬀerent primer combinations (10 two-base-
anchored oligo-dT and 23 arbitrary primers purified by
HPLC, Table 1).
Nontemplate (NT) and non-RT RNA (N-RT) template
reactions were used as negative controls. In each DDRT-
PCR set-up, reactions were performed at least in duplicate to
test whether diﬀerences in LV/RV gene expression are likely
to be real. PCR was performed, using the AmpliTaq DNA
polymerase (Invitrogen), under the following conditions:
initial denaturation (94◦C, 2 minutes), stage I (5 cycles,
each of which included: 94◦C, 30 seconds; 40◦C, 1 minute;
72◦C, 1 minute), stage II (25 cycles, each on which included:
94◦C, 30 seconds; 50◦C, 1 minute; 72◦C, 1 minute), and
final extension (72◦C, 10 minutes), sample store at 6◦C.
PCR-amplified products were subjected to fractionation on
8% polyacrylamide gels (PAAG) (Mini-Protean-III, Bio-
Rad) and fluorescently stained by SYBR Green I (Sigma).
Image acquisition and intensity of bands were estimated by
densitometry (VersaDoc 1000) and Quantity One software
(Bio-Rad). Diﬀerentially regulated amplification products
were defined as those bands that were similarly displayed at
least in two experimental replicates. Using a sharp, sterile
razor blade, a rectangular piece of gel corresponding to an
individual band of interest on the PAAG was excised and elec-
troeluted (D-tube Electroelution Kit, Novagen). After a short
centrifugation, the eluate was transferred to a clean tube.
The extracted DNA was used directly as the template for
PCR with T7 and M13 reamplification primers (see Table 1).
Cycling conditions were as described for DDRT-PCR except
stage I at 45◦C and stage II (20 cycles) at 55◦C. After
reamplification, each PCR reaction was electrophoresed
through a 1.5% agarose gel with ethidium bromide to assure
that the correct sized fragment was amplified. Reamplified
cDNA fragments were eluted (QIAquick Gel Extraction Kit,
Qiagen), cloned into pCRII-TOPO vector (Invitrogen), and
sequenced by (Secugen), (Madrid, Spain). The nucleotide
sequences obtained were compared with known sequences
by searching the GenBank database with BLAST algorithms.
2.4. Quantitative RT-PCR. Diﬀerential gene expression was
further confirmed by real-time quantitative PCR (qRT-PCR)
as described [13] using Bio-Rad IQ5 instrument and Bio-Rad
Table 1: Primers used in diﬀerential display RT-PCR analysis.
T7-Oligo(dT)
ACGACTCACTATAGGGCTTTTTTTTTTTTTT
two-base anchored oligo-dT antisense primers∗
H01 ACGACTCACTATAGGGCTTTTTTTTTTTTGA
H02 ACGACTCACTATAGGGCTTTTTTTTTTTTGC
H03 ACGACTCACTATAGGGCTTTTTTTTTTTTGG
H04 ACGACTCACTATAGGGCTTTTTTTTTTTTGT
H05 ACGACTCACTATAGGGCTTTTTTTTTTTTCA
H06 ACGACTCACTATAGGGCTTTTTTTTTTTTCC
H07 ACGACTCACTATAGGGCTTTTTTTTTTTTCG
H08 ACGACTCACTATAGGGCTTTTTTTTTTTTAA
H09 ACGACTCACTATAGGGCTTTTTTTTTTTTAC
H10 ACGACTCACTATAGGGCTTTTTTTTTTTTAG
10-mer arbitrary sense primers∗∗
A01 ACAATTTCACACAGGACGACTCCAAG
A02 ACAATTTCACACAGGAGCTAGCATGG
A03 ACAATTTCACACAGGAGACCATTGCA
A04 ACAATTTCACACAGGAGCTAGCAGAC
A05 ACAATTTCACACAGGAATGGTCGTCT
A06 ACAATTTCACACAGGATACAACGAGG
A07 ACAATTTCACACAGGATGGATTGGTC
A08 ACAATTTCACACAGGATGGTAAAGGG
A09 ACAATTTCACACAGGATAAGCCTAGC
A10 ACAATTTCACACAGGAGATCTCAGAC
A11 ACAATTTCACACAGGAACGCTAGTGT
A12 ACAATTTCACACAGGAGGTACTAAGG
A13 ACAATTTCACACAGGAGTTGCACCAT
A14 ACAATTTCACACAGGATCCATGACTC
A15 ACAATTTCACACAGGACTTTCTACCC
A16 ACAATTTCACACAGGATCGGTCATAG
A17 ACAATTTCACACAGGACTGCTAGGTA
A18 ACAATTTCACACAGGATGATGCTACC
A19 ACAATTTCACACAGGATTTTGGCTCC
A20 ACAATTTCACACAGGATCGATACAGG
A21 ACAATTTCACACAGGACAGGCAGCAG
A23 ACAATTTCACACAGGATATGGCGCCG
A24 ACAATTTCACACAGGAGCTGAACCGG
primers for reamplification of DD bands
T7 GTAATACGACTCACTATAGGGC
M13rev-48p AGCGGATAACAATTTCACACAGGA
∗Each anchor primer has T7 sequence (bold) on the 5′ end.
∗∗Each arbitrary primer has M13 sequence (bold) on the 5′ end.
SYBR Green Mix [14, 15]. Whenever possible, the primer
pairs were designed to be located in diﬀerent exons of a given
sequence. Individual heart-matched LV/RV cDNAs isolated
from three newborn and three 20-day-old piglets were used
as templates. Each primer pair used yielded a single peak
of dissociation on the melting curve and a single band
with expected size on PAAG [12]. A negative NT and N-
RT controls were included in each reaction set. Detection
of ribosomal protein L19 (RPL19) mRNA was used to
normalize the expression of target mRNAs. The eﬃciency of
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Figure 2: Diﬀerential display (DDRT-PCR) analysis of gene expression in left/right ventricles (LV/RV) of newborn piglets. (a) Representative
gel images of DDRT-PCR bands amplified with three distinct sets of primer combinations (H07-A09, H08-A19, and H09-A19), showing
highly reproducible band patterns in each replicate. Nondenaturing 8% PAAG poststained with SYBR Green I. 200–2500 bp—DNA size
standards (GeneRuler DNA ladder mix, Fermentas). (b and c) Number and size distribution frequencies of bands generated by DDRT-PCR.
target and reference amplification was tested and found to
be approximately equal. Results were defined as the target
genes expression normalized against rpl19 gene expression
in both ventricles. Fold changes were calculated using the
CT method. Primer sequences and additional details on qRT-
PCR are available upon request.
2.5. Data Analysis. Values were expressed as means ± SEM.
mRNA expression was quantified using the comparative
threshold cycle method. Statistical analyses were performed
with the SPSS 13 software. A P value < .05 was considered to
be statistically significant.
3. Results
3.1. DDRT-PCR Analysis Allows Reliable Transcriptomic Pro-
filing of Ventricular Myocardium in Newborn Piglets. For
mammalian cells, it was calculated that 20 arbitrary in
conjunction with 12 anchored primers would statistically
amplify all mRNA sequences [16]. We used 23 arbitrary and
10 two-base-oligo(dT) anchored primers (Table 1), resulting
in 230 display primer combinations. A total of about 5,600
distinct cDNA fragments corresponding to genes expressed
in piglet LV/RV myocardium were detected. A representative
example of DDRT-PCR banding patterns is illustrated in
Figure 2(a).
The average number of bands generated by one primer
pair was 26, the minimum was 0, and the maximum was
44. About 70% of the primer pairs produced 20–40 bands
(Figure 2(b)). Size distribution analysis of cDNA bands
generated by DDRT-PCR revealed a minor fraction of short-
sized (100–300 nt) bands, while the fragments with a size
from 300 to 1,000 nt, which is a preferable choice for cloning
and sequencing, made up about 60% of all detected bands
(Figure 2(c)).
Taken together, the results indicated that under our
experimental conditions, transcript-banding patterns gen-
erated by DDRT-PCR could be suﬃcient for comparative
expression analysis of the LV versus RV myocardium of
newborn piglets.
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Figure 3: Examples of the bands, displaying over twofold LV versus RV expression diﬀerences in newborn piglets. The primer pairs used for
DDRT-PCR amplifications are shown. Nondenaturing 8% PAAG poststained with SYBR Green I. LV/RV: left/right ventricle. 200–2500 bp:
DNA size standards (GeneRuler DNA ladder mix, Fermentas). Arrows: the bands (D106, D137, D123, and D132), which correspond to the
transcripts diﬀerentially displayed between LV and RV. For further details see Table 2.
3.2. DDRT-PCR Profiling Identifies Diﬀerentially Expressed
Genes in the LV versus RV Myocardium of Newborn Piglets.
Direct side-by-side comparison of the mRNAs between the
LV and RV of the newborn piglet heart revealed that the
majority of profiled genes (97%) were similarly expressed in
both ventricles. Out of more than 5,600 DDRT-PCR bands
amplified by the primer combinations used, a total of 153
bands, ranging in size from 300 to 1,000 nt, were identified
as being qualitatively diﬀerentially displayed. Of these, 96
transcripts were enriched in the LV, whereas the remaining
57 were predominant in the RV.
Figure 3 illustrates the relative diﬀerential expression of
a representative set of bands in the LV as compared to the
RV myocardium. Once diﬀerentially displayed PCR products
were detected, the fragments which displayed over twofold
LV-RV expression diﬀerences (40 bands) were recovered
from gels, reamplified, cloned, and sequenced. The diﬀeren-
tial expression of these genes was further confirmed using
qRT-PCR analysis. In this manner, over 80% (32 bands)
of the selected bands were confirmed to be diﬀerentially
expressed in the two ventricular chambers of newborn piglets
(Table 2).
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Figure 4: Estimation of myostatin (MSTN) mRNA levels in the LV and RV of newborn and 20-day-old piglets. (a) Representative qPCR
amplification plot of MSTN mRNA levels in the LV (red) and RV (blue) of three 20-day-old piglet hearts. Internal RPL19 reference levels
in the LV (red) and RV (blue) are shown. Arrows: threshold cycle (CT). FT: fluorescent threshold. ΔCT : diﬀerences in threshold cycles for
target and reference. NTC: nontemplate controls. B: MSTN mRNA levels in the LV versus RV ventricle of newborn and 20-day-old piglets.
∗P < .05, newborn piglets (n = 3). #P < .05, 20-day-old piglets (n = 3).
The BLAST searches for sequence similarity revealed that
6 of the 32 cloned cDNA fragments with confirmed diﬀeren-
tial expression are potentially novel transcripts with no sig-
nificant match in the current databases, suggesting that they
may either encode as yet uncharacterized proteins or corre-
spond to unknown regions of identified genes (untranslated,
nonconserved regions). The remaining 26 cDNA sequences
were identified by BLAST sequence comparisons as genes
related to modulation of gene expression (PTPLAD1, PHB2,
CEP290, JMJD1C), regulation of cell growth and diﬀeren-
tiation (MSTN, MAP3K71P2, APOBEC3F, PHB2), biome-
chanical stress sensing and myofibrilar assembly (TTN,
ANKRD1), muscle contraction (TNNT2, ACTC1), extra-
cellular matrix remodeling (ADAMTS3, COL1A2), calcium
control (SLC8A1), and energy metabolism (ATP5C1, ND6).
Table 2 provides details of the extent of relative LV/RV
upregulation (fold change) as well as the known function(s)
of identified genes. Among the diﬀerentially expressed
genes, only a small portion displayed over 4-fold expression
diﬀerences between LV and RV (PTPLAD1, TPM2, ACTC1,
ANKRD1, ANKRD1-I8, PDE3A, D162, TNMD, D170). In
this sense, chamber-dependent regulation of expression
of these known and novel transcripts may be primarily
associated with diﬀerent patterns of postnatal ventricular
remodeling.
MSTN (myostatin) characterized by LV-predominant
expression in newborn myocardium also stood out as an
interesting candidate, given its roles in cell growth and
proliferation. Recently, it has been demonstrated that MSTN
is a potent repressor of cardiac muscle cell proliferation and
growth, and that in vivo loss of MSTN induces eccentric
hypertrophy associated with enhanced responsiveness of
ventricular myocytes to beta-adrenergic stimulation [17,
18]. We, therefore, examined this gene expression in both
ventricles at advanced stages of postnatal development when
morphological diﬀerences between concentric (LV) and
eccentric (RV) remodeling become evident, that is in 20-
day-old piglets (see Figure 1(d)). The LV/RV MSTN mRNA
ratio found in newborn piglets (i.e., 2 : 1) was significantly
amplified in 20-day-old animals (i.e., 6 : 1) due to MSTN
upregulation in the LV of the latter age group, while the
gene’s expression levels in the RV were similar in two groups
studied (Figure 4). The results indicate that in neonatal
piglets a process of RV-eccentric remodeling is associated
with the same relative low MSTN level as was found in the
RV at birth.
Collectively, the comparison of gene expression between
the LV and RV shortly after birth, when LV/RV loading
conditions are dramatically changed as compared to the late-
fetal period, demonstrates that such analysis provides clues
for identifying hallmark genes whose expression is regulated
in a chamber-dependent manner at the earliest stages of
postnatal LV-concentric and RV-eccentric remodeling.
4. Discussion
The DDRT-PCR technique, which was first developed in
1992 [19], is still the method of choice for an unbiased
comparison of mRNA expression patterns between samples
that are very similar and often results in identification of
nonabundant, rare, or novel transcripts [10, 20, 21].
Using a nonradioactive DDRT-PCR technique, we iden-
tified the transcripts that reproducibly showed diﬀerent
expression levels between LV and RV in newborn piglets.
These diﬀerences do not correlate with either cardiomyocyte
cell volume [22] or ventricular wall thickness ([9]; see
also Figure 1(b), this work), which are practically equal in
both piglet ventricles during or shortly after birth. Thus, in
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this system a molecular prepattern precedes the appearance
of morphologically identifiable signs of LV-concentric and
RV-eccentric hypertrophy. We suggest that the observed
diﬀerences in gene expression are intrinsic to the distinct
molecular makeup of the LV versus RV rather than to their
hyperplastic/hypertrophic growth status, which is similar in
both ventricles at birth. Further, the content of certain well-
known markers of cardiomyocyte hypertrophy (beta-myosin
heavy chain and myosin light chain 2 ventricular) was found
to be similar in both the LV and RV of newborn piglets [9].
Moreover, expression levels of the transcriptional cofactor,
myocardin, which induces cardiomyocyte hypertrophy [23,
24], are equal in both ventricles of these animals [25]. There-
fore, it seems reasonable to interpret the diﬀerences in gene
expression detected in our present work as indicative of an
L–R molecular predisposition of the newborn myocardium
to respond to dramatic changes of the hemodynamic loads
shortly after birth when the LV is exposed to a higher-
pressure load (concentric hypertrophy promoting condition)
in comparison to the RV, which is exposed to a higher-
volume load (eccentric hypertrophy promoting condition).
The vast majority of the transcripts diﬀerentially
expressed in the LV and RV of newborn piglets corre-
spond to genes which were not previously known to be
asymmetrically expressed in the LV versus RV myocardium,
excepting those coding for beta-spectrin [4], ANKRD1 [9],
BNP [6, 9], calcium ATPase, matrix metalloproteinases,
type 1 procollagens, and troponins [3]. In addition, other
reports demonstrated that transcripts for proteins such as
fibronectin, alpha-myosin heavy chain and transforming
growth factor [26], and cytochrome c oxidase and heart
isoforms of uncoupling proteins [27] are asymmetrically
enriched in the LV versus RV mammalian myocardium.
Regulatory mechanisms resulting in LV/RV transcrip-
tional diﬀerences in the newborn and early neonatal heart
are largely unknown, but of special interest, because the
functionally diﬀerent roles of the two ventricles become
apparent after birth. Our study characterizes the transcrip-
tion status of the LV and RV at birth rather than the
establishment of LV/RV transcription diﬀerences in the
course of development [28]. In embryonic and fetal heart,
expression of a number of transcription factors, including
Hand1, Hand2, and Tbx5, shows LV/RV diﬀerences [29, 30].
We found [9] that Hand1 and Hand2 are equally expressed
in both the LV and RV of newborn piglets, suggesting that
these factors are not involved in maintaining L/R ventricular
transcriptional diﬀerences after birth.
In this work, among the genes whose expression levels
diﬀerentiate between the LV and RV, there is a small cohort
of genes which could be involved in concentric versus
eccentric hypertrophy signalling (see Table 2). In this regard,
several key regulators of muscle cell growth and prolifer-
ation (MAP3K7IP2, MSTN, PHB2, APOBEC3F) and gene
expression (PTPLAD1, JMJD1C, CEP290) are diﬀerentially
expressed between LV and RV piglet myocardium that may
be relevant to intrinsic diﬀerences [31] that can regulate
the chamber-dependent response of ventricular myocardium
to workload. Interestingly, transition from “early” to “late”
hypertension-induced hypertrophy in young adult rats is
associated with predominant changes in expression of cell
growth/proliferation and signal transduction factors [32].
Sequence analysis of the 32 cDNAs chosen based on
diﬀerential LV/RV screening revealed a number of sequences,
which may correspond to either previously uncharacterized
genes or yet unidentified splice variants of the known
cardioexpressed genes. In this sense, identification of the D36
fragment sequence (see Table 2) as being completely identical
to that located within intron 8 of the pig ankrd1 gene led us
to isolate and characterize three novel alternatively spliced
ankrd1 variants which are predominantly expressed in the LV
of neonatal and adult pig and human hearts and markedly
upregulated in the ventricular myocardium at experimental
heart failure [12]. Similarly, the D170 fragment (see Table 2),
exhibiting homology with exon 1 and 3 sequences of the pig
nppb gene, may represent a new form of alternative splicing
of this cardioprotective factor.
Various cardiac disease states can result in an imbalance
of chamber-associated expression patterns in ventricular
myocardium. In the rat infarct model, a shift in chamber-
dependent gene expression towards relative downregulation
of gene expression in the RV as compared to the LV has
been reported [3]. In the porcine model of cardiotoxic
cardiomyopathy we have demonstrated that the normal
asymmetric LV/RV pattern of ANKRD1 mRNA and protein
distribution was completely abolished at end-stage heart
failure; improvement of cardiac performance resulted in
the restoration of this gene’s LV/RV asymmetric expression
[9]. In the pig model of volume overload (eccentric hyper-
trophy promoting condition), angiotensinogen and prepro-
endothelin expression levels were significantly upregulated
in the RV while remaining uncharged in the LV [31]. In the
mouse model of RV pressure-overload hypertrophy, over 10
transcripts showed significant upregulation in the afterload
stressed RV, but not in the afterload stressed LV, including
three genes from the Wnt signaling pathway, and genes
involved in apoptosis [33]. In young rats, chronic hypoxia
resulted in a shift from an LV- to an RV-predominant pattern
in cytochrome c oxidase expression [27].
In sum, although not all of the identified genes with
diﬀerential LV/RV expression have a clearly defined cardiac-
related function(s) at this time, the results of our work do
advance the understanding of the complex mechanisms that
could be involved in concentric versus eccentric remodeling
of ventricular myocardium under normal conditions. More
broadly, the identification of specific expression signatures
of concentric versus eccentric hypertrophy may be useful
in the elucidation of molecular pathways involved not
only in physiological but also in pathological myocardial
remodelling and heart failure.
5. Conclusions
Using an unbiased DDRT-PCR analysis, we were able to
identify a set of genes with divergent LV versus RV expres-
sion. To our knowledge, this is the first study to account
for large-scale gene expression profiling in early neonatal
myocardium in mammals which revealed a certain molecular
predisposition of the LV and RV, respectively, to concentric
Journal of Biomedicine and Biotechnology 9
or eccentric hypertrophic remodeling. The reliability of these
findings is supported by confirmation of the results by
qRT-PCR and recognition of a fraction of the diﬀerentially
expressed genes as known genes involved in pathological
ventricular remodeling and heart failure. In addition, our
data demonstrate chamber-dependent alterations in the
expression of as yet uncharacterised novel genes that may be
associated with diﬀerent patterns of ventricular hypertrophic
remodeling and can be used to study a board range of heart
disease phenotypes.
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